Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Taiwan-based Enterprises AP Biosciences and LuminX Novel Cancer Treatments 2020-12-01 00:00
Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing 2020-11-27 21:00
Breakthrough in AML Treatment: GoldenBiotech Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia 2020-11-26 21:35
China Biologic Reports Financial Results for the Third Quarter of 2020 2020-11-25 05:30
NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium 2020-11-24 22:26
OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain 2020-11-24 22:00
WPI-MANA Team: Biogenic Iron Sulfide Nanoparticles Enable Electron Uptake in Bacteria 2020-11-20 14:00
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction 2020-11-19 21:09
WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory 2020-11-18 21:00
Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility 2020-11-18 20:00
Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments 2020-11-17 20:00
Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of Camcevi(TM) in China 2020-11-17 17:51
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center 2020-11-14 12:40
China Biologic Products to Report Third Quarter 2020 Financial Results 2020-11-13 21:00
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update 2020-11-09 21:00
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
1 115 116 117 118 119 222